Trial intelligence / Profile preview

Effect of zinc on hyperbilirubinemia in newborns

IRCT2017061515835N5Phase 3Completed

Sponsor
Zanjan University of Medical Sciences
Start
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of zinc in physiological neonatal jaundice and neonatal hyperbilirubinemia, sponsored by Zanjan University of Medical Sciences. Started Dec 2017; status: completed.

02

Drugs

zinc
03

Conditions

physiological neonatal jaundiceneonatal hyperbilirubinemia

Beyond the preview

Go deeper on IRCT2017061515835N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017061515835N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call